Terms: = Kidney tumors AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Treatment
86 results:
1. Targeting apoptosis and unfolded protein response: the impact of β-hydroxybutyrate in clear cell renal cell carcinoma under glucose-deprived conditions.
Roohy F; Siri M; Kohansal K; Ghalandari A; Rezaei R; Maleki MH; Shams M; Monsef A; Dastghaib S
Mol Biol Rep; 2024 Jan; 51(1):168. PubMed ID: 38252187
[TBL] [Abstract] [Full Text] [Related]
2. Afatinib-Induced Tumor Lysis Syndrome in Pulmonary Adenocarcinoma: A Case Report and Literature Review.
Hong G
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138247
[TBL] [Abstract] [Full Text] [Related]
3. Collision kidney Tumor Consisting of Clear Cell Renal Cell Carcinoma and Primary Renal Mantle Cell Lymphoma: A Case Report.
Yang H; Wang P
Arch Esp Urol; 2023 Oct; 76(8):627-632. PubMed ID: 37960962
[TBL] [Abstract] [Full Text] [Related]
4. Knockdown of NR3C1 inhibits the proliferation and migration of clear cell renal cell carcinoma through activating endoplasmic reticulum stress-mitophagy.
Yan M; Wang J; Wang H; Zhou J; Qi H; Naji Y; Zhao L; Tang Y; Dai Y
J Transl Med; 2023 Oct; 21(1):701. PubMed ID: 37807060
[TBL] [Abstract] [Full Text] [Related]
5. Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma.
Zhang D; Ni Y; Wang Y; Feng J; Zhuang N; Li J; Liu L; Shen W; Zheng J; Zheng W; Qian C; Shan J; Zhou Z
J Transl Med; 2023 Jul; 21(1):489. PubMed ID: 37474942
[TBL] [Abstract] [Full Text] [Related]
6. [Cordycepin, a metabolite of
Zheng Q; Shao Y; Zheng W; Zou Y
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):873-878. PubMed ID: 37439158
[TBL] [Abstract] [Full Text] [Related]
7. Prediction values of tertiary lymphoid structures in the prognosis of patients with left- and right-sided colon cancer: a multicenter propensity score-matched study.
Mao Y; Wang X; Xi L; Dong M; Song P; Miao J; Lu C; Sun S; Li Q; Yu C; Shen X
Int J Surg; 2023 Aug; 109(8):2344-2358. PubMed ID: 37247038
[TBL] [Abstract] [Full Text] [Related]
8. Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
Ng KW; Boumelha J; Enfield KSS; Almagro J; Cha H; Pich O; Karasaki T; Moore DA; Salgado R; Sivakumar M; Young G; Molina-Arcas M; de Carné Trécesson S; Anastasiou P; Fendler A; Au L; Shepherd STC; Martínez-Ruiz C; Puttick C; Black JRM; Watkins TBK; Kim H; Shim S; Faulkner N; Attig J; Veeriah S; Magno N; Ward S; Frankell AM; Al Bakir M; Lim EL; Hill MS; Wilson GA; Cook DE; Birkbak NJ; Behrens A; Yousaf N; Popat S; Hackshaw A; ; ; Hiley CT; Litchfield K; McGranahan N; Jamal-Hanjani M; Larkin J; Lee SH; Turajlic S; Swanton C; Downward J; Kassiotis G
Nature; 2023 Apr; 616(7957):563-573. PubMed ID: 37046094
[TBL] [Abstract] [Full Text] [Related]
9. Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era.
Vassilakopoulos TP; Panitsas F; Mellios Z; Apostolidis J; Michael M; Gurion R; Ferhanoglu B; Hatzimichael E; Karakatsanis S; Dimou M; Kalpadakis C; Katodritou E; Leonidopoulou T; Kotsianidis I; Giatra H; Kanellias N; Sayyed A; Tadmor T; Akay OM; Angelopoulou MK; Horowitz N; Bakiri M; Pangalis GA; Panayiotidis P; Papageorgiou SG
Hematol Oncol; 2023 Feb; 41(1):97-107. PubMed ID: 36314897
[TBL] [Abstract] [Full Text] [Related]
10. The tricks for fighting against cancer using CAR NK cells: A review.
Vahidian F; Khosroshahi LM; Akbarzadeh M; Jahanban-Esfahlan A; Baghbanzadeh A; Ali-Hassanzadeh M; Safarzadeh E
Mol Cell Probes; 2022 Jun; 63():101817. PubMed ID: 35436564
[TBL] [Abstract] [Full Text] [Related]
11. Acute kidney Injury in Patients With Cancer: A Review of Onconephrology.
Gudsoorkar P; Langote A; Vaidya P; Meraz-Muñoz AY
Adv Chronic Kidney Dis; 2021 Sep; 28(5):394-401.e1. PubMed ID: 35190106
[TBL] [Abstract] [Full Text] [Related]
12. Single-Dose Rasburicase Might Be Adequate To Overcome Tumor Lysis Syndrome In Hematological Malignancies.
Yaman S; Başcı S; Turan G; Ulu BU; Yiğenoğlu TN; Dal MS; Kızıl Çakar M; Altuntaş F
Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):e71-e76. PubMed ID: 34565690
[TBL] [Abstract] [Full Text] [Related]
13. Integrated Analysis Of Immunotherapy Treated Clear Cell Renal Cell Carcinomas: An Exploratory Study.
Sobottka B; Nienhold R; Nowak M; Hench J; Haeuptle P; Frank A; Sachs M; Kahraman A; Moch H; Koelzer VH; Mertz KD
J Immunother; 2022 Jan; 45(1):35-42. PubMed ID: 34406159
[TBL] [Abstract] [Full Text] [Related]
14. Chronic kidney disease linked to SARS-CoV-2 infection: a case report.
Tarris G; de Rougemont A; Estienney MA; Journet J; Lariotte AC; Aubignat D; Rebibou JM; De La Vega MF; Legendre M; Belliot G; Martin L
BMC Nephrol; 2021 Aug; 22(1):278. PubMed ID: 34376184
[TBL] [Abstract] [Full Text] [Related]
15. Intratumoral CXCL13
Dai S; Zeng H; Liu Z; Jin K; Jiang W; Wang Z; Lin Z; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Qu Y; Guo J; Xu J
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589528
[TBL] [Abstract] [Full Text] [Related]
16. Prevention and treatment of Tumor Lysis Syndrome in the Era of Onco-Nephrology Progress.
Matuszkiewicz-Rowinska J; Malyszko J
Kidney Blood Press Res; 2020; 45(5):645-660. PubMed ID: 32998135
[TBL] [Abstract] [Full Text] [Related]
17. Spontaneous Tumor Lysis Syndrome in Blastoid-Variant Mantle Cell Lymphoma: Considerations for the General Internist.
Patel V; Case R
J Investig Med High Impact Case Rep; 2020; 8():2324709620944709. PubMed ID: 32720820
[TBL] [Abstract] [Full Text] [Related]
18. Comparative effectiveness of rasburicase versus allopurinol for cancer patients with renal dysfunction and hyperuricemia.
Martens KL; Khalighi PR; Li S; White AA; Silgard E; Frieze D; Estey E; Garcia DA; Hingorani S; Li A
Leuk Res; 2020 Feb; 89():106298. PubMed ID: 31945598
[TBL] [Abstract] [Full Text] [Related]
19. MCP-1/MCPIP-1 Signaling Modulates the Effects of IL-1β in Renal Cell Carcinoma through ER Stress-Mediated Apoptosis.
Lee CH; Hung PF; Lu SC; Chung HL; Chiang SL; Wu CT; Chou WC; Sun CY
Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31816951
[TBL] [Abstract] [Full Text] [Related]
20. ABT-263 exhibits apoptosis-inducing potential in oral cancer cells by targeting C/EBP-homologous protein.
Yang IH; Jung JY; Kim SH; Yoo ES; Cho NP; Lee H; Lee JY; Hong SD; Shin JA; Cho SD
Cell Oncol (Dordr); 2019 Jun; 42(3):357-368. PubMed ID: 30919222
[TBL] [Abstract] [Full Text] [Related]
[Next]
